148 related articles for article (PubMed ID: 31056981)
1. Pro-inflammatory and pro-resolving mechanisms in the immunopathology of arteriovenous fistula maturation.
Satish M; Gunasekar P; Agrawal DK
Expert Rev Cardiovasc Ther; 2019 May; 17(5):369-376. PubMed ID: 31056981
[No Abstract] [Full Text] [Related]
2. Future research directions to improve fistula maturation and reduce access failure.
Hu H; Patel S; Hanisch JJ; Santana JM; Hashimoto T; Bai H; Kudze T; Foster TR; Guo J; Yatsula B; Tsui J; Dardik A
Semin Vasc Surg; 2016 Dec; 29(4):153-171. PubMed ID: 28779782
[TBL] [Abstract][Full Text] [Related]
3. Vascular remodeling and intimal hyperplasia in a novel murine model of arteriovenous fistula failure.
Wong CY; de Vries MR; Wang Y; van der Vorst JR; Vahrmeijer AL; van Zonneveld AJ; Roy-Chaudhury P; Rabelink TJ; Quax PH; Rotmans JI
J Vasc Surg; 2014 Jan; 59(1):192-201.e1. PubMed ID: 23684425
[TBL] [Abstract][Full Text] [Related]
4. Elastin is a key regulator of outward remodeling in arteriovenous fistulas.
Wong CY; Rothuizen TC; de Vries MR; Rabelink TJ; Hamming JF; van Zonneveld AJ; Quax PH; Rotmans JI
Eur J Vasc Endovasc Surg; 2015 Apr; 49(4):480-6. PubMed ID: 25701072
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand Factor: A Central Regulator of Arteriovenous Fistula Maturation Through Smooth Muscle Cell Proliferation and Outward Remodeling.
Laboyrie SL; de Vries MR; de Jong A; de Boer HC; Lalai RA; Martinez L; Vazquez-Padron RI; Rotmans JI
J Am Heart Assoc; 2022 Aug; 11(16):e024581. PubMed ID: 35929448
[TBL] [Abstract][Full Text] [Related]
6. Molecular Targets for Improving Arteriovenous Fistula Maturation and Patency.
Gorecka J; Fereydooni A; Gonzalez L; Lee SR; Liu S; Ono S; Xu J; Liu J; Taniguchi R; Matsubara Y; Gao X; Gao M; Langford J; Yatsula B; Dardik A
Vasc Investig Ther; 2019; 2(2):33-41. PubMed ID: 31608322
[TBL] [Abstract][Full Text] [Related]
7. A new arteriovenous fistula model to study the development of neointimal hyperplasia.
Manning E; Skartsis N; Orta AM; Velazquez OC; Liu ZJ; Asif A; Salman LH; Vazquez-Padron RI
J Vasc Res; 2012; 49(2):123-31. PubMed ID: 22249138
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of T-Cells by Cyclosporine A Reduces Macrophage Accumulation to Regulate Venous Adaptive Remodeling and Increase Arteriovenous Fistula Maturation.
Matsubara (松原裕) Y; Kiwan G; Liu (刘佳) J; Gonzalez L; Langford J; Gao (高明杰) M; Gao (高喜翔) X; Taniguchi (谷口良輔) R; Yatsula B; Furuyama (古山正) T; Matsumoto (松本拓也) T; Komori (古森公浩) K; Dardik A
Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):e160-e174. PubMed ID: 33472405
[TBL] [Abstract][Full Text] [Related]
9. New Developments in Our Understanding of Neointimal Hyperplasia.
Lee T; Ul Haq N
Adv Chronic Kidney Dis; 2015 Nov; 22(6):431-7. PubMed ID: 26524947
[TBL] [Abstract][Full Text] [Related]
10. One-year patency rate of native arteriovenous fistulas reconstructed by vascular stripping in hemodialysis patients with venous neointimal hyperplasia.
Lu FP; Liu LP; Lu ZX
J Vasc Surg; 2015 Jan; 61(1):192-6. PubMed ID: 25135873
[TBL] [Abstract][Full Text] [Related]
11. Localized Perivascular Therapeutic Approaches to Inhibit Venous Neointimal Hyperplasia in Arteriovenous Fistula Access for Hemodialysis Use.
Barcena AJR; Perez JVD; Liu O; Mu A; Heralde FM; Huang SY; Melancon MP
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291576
[TBL] [Abstract][Full Text] [Related]
12. Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases.
Satish M; Agrawal DK
Expert Rev Cardiovasc Ther; 2019 Mar; 17(3):177-184. PubMed ID: 30582389
[TBL] [Abstract][Full Text] [Related]
13. Innate and adaptive immune cells associate with arteriovenous fistula maturation and failure.
Samra G; Rai V; Agrawal DK
Can J Physiol Pharmacol; 2022 Aug; 100(8):716-727. PubMed ID: 35671528
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic Analysis Identifies Differentially Expressed Genes Associated with Vascular Cuffing and Chronic Inflammation Mediating Early Thrombosis in Arteriovenous Fistula.
Rai V; Agrawal DK
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203642
[TBL] [Abstract][Full Text] [Related]
15. Pre-existing arterial pathologic changes affecting arteriovenous fistula patency and cardiovascular mortality in hemodialysis patients.
Lee JY; Kim YO
Korean J Intern Med; 2017 Sep; 32(5):790-797. PubMed ID: 28823140
[TBL] [Abstract][Full Text] [Related]
16. Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling.
Conte MS; Nugent HM; Gaccione P; Roy-Chaudhury P; Lawson JH
J Vasc Surg; 2011 Nov; 54(5):1383-9. PubMed ID: 21840154
[TBL] [Abstract][Full Text] [Related]
17. Improving arteriovenous fistula patency: Transdermal delivery of diclofenac reduces cannulation-dependent neointimal hyperplasia via AMPK activation.
MacAskill MG; Watson DG; Ewart MA; Wadsworth R; Jackson A; Aitken E; MacKenzie G; Kingsmore D; Currie S; Coats P
Vascul Pharmacol; 2015 Aug; 71():108-15. PubMed ID: 25866325
[TBL] [Abstract][Full Text] [Related]
18. Arteriovenous access failure: more than just intimal hyperplasia?
Rothuizen TC; Wong C; Quax PH; van Zonneveld AJ; Rabelink TJ; Rotmans JI
Nephrol Dial Transplant; 2013 May; 28(5):1085-92. PubMed ID: 23543595
[TBL] [Abstract][Full Text] [Related]
19. [Patency rate of autogenous arteriovenous fistula after repairment in the patients with late fistula dysfunction/faliure].
Zhou M; Lu FP
Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(15):1175-1178. PubMed ID: 28427126
[No Abstract] [Full Text] [Related]
20. Distinct subsets of T cells and macrophages impact venous remodeling during arteriovenous fistula maturation.
Matsubara Y; Kiwan G; Fereydooni A; Langford J; Dardik A
JVS Vasc Sci; 2020; 1():207-218. PubMed ID: 33748787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
